We describe a 56-year-old man who developed an acute liver injury after taking alfuzosin for 1 month to control his newly diagnosed benign prostatic hypertrophy (BPH). There was no history of alcohol consumption or the taking herbal or traditional remedies. Viral causes, autoimmune hepatitis, and biliary tree obstruction were excluded. Other rare causes of hepatitis such as hemochromatosis, primary biliary cirrhosis and Wilson’s disease were also absent in this patient. His liver test results began to improve after discontinuing the alfuzosin. Two weeks later, alfuzosin was administered again because the patient complained of dysuria. After 10 days of alfuzosin reuse, his liver test results worsened. Five months later after the complete discontinuation of the drug, his liver test results had returned to normal. This clinical sequence suggests that alfuzosin caused his acute liver injury. (Korean J Hepatol 2007;13:414-418)
Interactive precision medicine revolution: unleashing a deep learning framework for drug response and recommendation Mallikarjuna Rao Gundavarapu, Raghavender Kotla Venkata, S. Bhargavi Latha, Pavan Kumar N. V., Ashlin Deepa R. N., Evgeny Vladimirovich Kotov, Rishi Dev Nautiyal, Laith H. Alzubaidi Cogent Engineering.2024;[Epub] CrossRef
Crude extract of Jatobá leaves promotes canine osteosarcoma cell D17 proliferation V. S. Vieira, V. S. Cruz, L. L. Nepomuceno, N. P. Soares, E. Arnhold, W. F. P. Teixeira, D. S. Vieira, J. C. A. Borges, F. M. Paixão, E. G. Araújo Veterinary World.2022; : 1283. CrossRef
Lower urinary tract symptoms in patients with liver cirrhosis Markus Margreiter, Birgit B. Heinisch, Remy Schwarzer, Tobias Klatte, Shahrokh F. Shariat, Arnulf Ferlitsch World Journal of Urology.2015; 33(3): 315. CrossRef
Acute Hepatocellular Drug Induced Liver Injury Probably by Alfuzosin Tufan Cicek, Huseyin Savas Gokturk, Gulhan Kanat Unler Case Reports in Urology.2015; 2015: 1. CrossRef
A case of severe liver injury induced by silodosin Norihiro Nomura, Takayoshi Ito, Yasuaki Kanada, Shinichi Shima, Takahiro Hobo, Takahiro Hayashi, Masashi Satou, Dai Sakuma, Junichi Eguchi, Keitarou Mitamura, Yoshio Deguchi, Masaaki Matukawa, Koji Saitou, Haruhiro Inoue Kanzo.2014; 55(11): 670. CrossRef
In vitroandin vivoevaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride Anroop B. Nair, Siva Ram Kiran Vaka, Sumit Gupta, Michael A. Repka, S. Narasimha Murthy Pharmaceutical Development and Technology.2012; 17(2): 158. CrossRef
Lesión hepatocelular recurrente por alfuzosina José Carlos Titos-Arcos, Hacibe Hallal, Raúl J. Andrade, Aurelio López Martín Gastroenterología y Hepatología.2011; 34(2): 125. CrossRef
Detective Work in Drug-Induced Liver Injury: Sometimes It Is All About Interviewing the Right Witness A. Sidney Barritt, Joseph Lee, Paul H. Hayashi Clinical Gastroenterology and Hepatology.2010; 8(7): 635. CrossRef
Drug-induced liver injury in 2007 William Norris, Angelo H Paredes, James H Lewis Current Opinion in Gastroenterology.2008; 24(3): 287. CrossRef
